PMID- 23268137 OWN - NLM STAT- MEDLINE DCOM- 20130930 LR - 20130429 IS - 1878-5492 (Electronic) IS - 0966-3274 (Linking) VI - 28 IP - 2-3 DP - 2013 Mar TI - Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. PG - 100-5 LID - S0966-3274(12)00134-7 [pii] LID - 10.1016/j.trim.2012.12.002 [doi] AB - Microchimerism after liver transplantation is considered to promote graft tolerance or tissue repair, but its significance is controversial. By using multiplex polymerase chain reaction (PCR) of short tandem repeat (STR) loci after laser capture microdissection of hepatocyte nuclei, we compared the proportions of recipient-derived hepatocytes in long-term stable liver allografts and late dysfunctional allografts caused by chronic rejection or idiopathic post-transplantation hepatitis. Through fluorescence in situ hybridization (FISH), we also analyzed the presence of recipient-derived Y-positive hepatocytes in the biopsies of livers transplanted from female donors to male recipients. The study population comprised 24 pediatric liver transplant recipients who survived with the initial graft, whose 10-year protocol biopsy records were available, and who had normal liver function (stable graft, SG; n=13) or a late dysfunctional graft (LDG; n=11) with similar follow-up periods (mean 10.8years in the SG group and 11.2years in the LDG group). STR analysis revealed that hepatocyte chimerism occurred in 7 of 13 (54%) SGs and 5 of 11 (45%) LDGs (p=0.68). The proportion of hepatocyte chimerism was low, with a mean of 3% seen in 2 of 3 female-to-male transplanted livers (one each of SG and LDG). In conclusion, hepatocyte chimerism was a constant event. The extent of engraftment of recipient-derived hepatocytes does not seem to correlate with the degree of hepatic injury in long-term liver allografts. CI - Copyright (c) 2013 Elsevier B.V. All rights reserved. FAU - Aini, Wulamujiang AU - Aini W AD - Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan. FAU - Miyagawa-Hayashino, Aya AU - Miyagawa-Hayashino A FAU - Ozeki, Munetaka AU - Ozeki M FAU - Tsuruyama, Tatsuaki AU - Tsuruyama T FAU - Tamaki, Keiji AU - Tamaki K FAU - Uemoto, Shinji AU - Uemoto S FAU - Haga, Hironori AU - Haga H LA - eng PT - Journal Article DEP - 20121222 PL - Netherlands TA - Transpl Immunol JT - Transplant immunology JID - 9309923 SB - IM MH - *Chimerism MH - Female MH - Follow-Up Studies MH - Graft Rejection/*immunology MH - Hepatocytes/*immunology MH - Humans MH - Liver Transplantation/*immunology MH - Male MH - Transplantation, Homologous MH - Treatment Outcome EDAT- 2012/12/27 06:00 MHDA- 2013/10/01 06:00 CRDT- 2012/12/27 06:00 PHST- 2012/10/04 00:00 [received] PHST- 2012/11/24 00:00 [revised] PHST- 2012/12/08 00:00 [accepted] PHST- 2012/12/27 06:00 [entrez] PHST- 2012/12/27 06:00 [pubmed] PHST- 2013/10/01 06:00 [medline] AID - S0966-3274(12)00134-7 [pii] AID - 10.1016/j.trim.2012.12.002 [doi] PST - ppublish SO - Transpl Immunol. 2013 Mar;28(2-3):100-5. doi: 10.1016/j.trim.2012.12.002. Epub 2012 Dec 22.